Infectious Disease

Reports of high-impact infectious disease studies by medical professionals

Clinical outcomes of COVID-19 in patients 6-months after hospital discharge in Wuhan, China

1. Fatigue or muscle weakness, sleep difficulties, and anxiety or depression were the most common symptoms among recovered patients 6 months after discharge. 2. Patients...

Early high-titer plasma therapy may reduce progression of COVID-19 in older patients

1. Patients aged 65 years or greater who received convalescent plasma within 72 hours of symptom onset were less likely to develop severe respiratory...

Rapid antigen testing for SARS-CoV-2 infection found to have limited accuracy for a pediatric...

1. Among a pediatric cohort, rapid antigen testing for SARS-CoV-2 infection was found to have limited accuracy when compared with reverse-transcriptase polymerase chain reaction...

REGN-COV2 antibody cocktail may reduces viral load in Covid-19 patients

1. In this interim analysis, patients who received REGN-COV2 had significantly greater decreases in viral load from baseline compared to those who received placebo. 2....

Increased close contact leads to spread of Andes virus in Argentina

1. Extensive person to person contact demonstrated high viral titer load of Andes orthohantavirus (ANDV) in Argentina. 2. The results indicated that epidemic possibility should...

Fractional doses of yellow fever vaccines are non-inferior to standard doses in seroconversion at...

1. One-fifth fractional doses from all four live attenuated yellow fever virus vaccines met the non-inferiority criterion. 2. The most common treatment-related adverse events were...

Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of...

1. Based on mathematical modeling, cross-reactivity between SARS-CoV-2 and other endemic human coronaviruses may explain variations in disease severity across age groups. Evidence Rating Level:...

Hydroxychloroquine may not prevent Covid-19 after contact exposure

1. Postexposure hydroxychloroquine therapy did not prevent coronavirus disease 2019 (Covid-19) infection in exposed healthy individuals. 2. Hydroxychloroquine treatment after exposure to a positive case...

Convalescent plasma may not improve outcomes in Covid-19 patients

1. Convalescent plasma did not improve clinical outcomes in patients with severe pneumonia due to coronavirus disease 2019 (Covid-19) compared to placebo. 2. Convalescent plasma...

O and Rh– blood groups may be associated with decreased risk for SARS-CoV-2 infection

1. Patients with type O blood were found to be at lower risk for SARS-CoV-2 infection, severe COVID-19, and death compared to the composite...

All-time hits